湖北省消除丝虫病后监测分析  

Surveillance and Evaluation after the Elimination of Lymphatic Filariasis in Hubei Province

作　　者：詹发先[1] 董小蓉[1] 陈建设[1] 胡乐群[1] 张华勋[1] 裴速建[1] 王莉莉[1] 余品红[1] 

机构地区：[1]湖北省疾病预防控制中心,湖北武汉430079

出　　处：《中国热带医学》2011年第11期1361-1362,共2页China Tropical Medicine

摘　　要：目的了解消除丝虫病后远期效果,监测丝虫病流行动态,防止丝虫病再度传播。方法采用病原学结合血清学监测的方法,对可能遗留残存传染源的地区进行主动搜索,追踪观察原微丝蚴血症者,核实临床诊断和疑似病例,另对慢性丝虫病患者实施照料。结果2001～2007年血检23 275人,未发现微丝蚴血症者。2001～2006年对原班氏微丝蚴血症者追踪观察783人次,未发现复阳微丝蚴血症者。2000年原班氏丝虫病地区以ICT卡检测人群丝虫循环抗原,1 929人中未发现阳性。2008年丝虫病重点地区IgG4抗体检测阳性率0.05%,阳性者亦未发现微丝蚴。2004～2008年调查排除22例丝虫病临床诊断和疑似丝虫病例。26个县(市)调查发现3 061例遗留慢性丝虫病患者,1例新发慢性丝虫病患者。结论湖北省消除丝虫病后没有发现内源性传染源,丝虫病防治成果巩固。Objective To understand the long-term effort and the trends of endemic situation of filariasis after the elimination of lymphatic filariasis and to prevent of lymphatic filariasis recurrence.Methods The serological and etiological methods was used to investigate the areas where residual source of infection might exist.To follow up the former microfilaremia cases in the former endemic areas were conducted.The clinically diagnosed cases and suspected cases were verified and the caring was taken for the chronic patients.Results From 2001 to 2007,23275 human blood samples were examined and no microfilaremia case was found.783 former microfilarimias were surveyed from 2001 to 2006 and no positive case was found.1929 ICT examinations were made for the filariasis circulating antigens in 2000 in bancroflian filariasis epidemic areas and no positive case was found.The positive rate of the IgG4 tests in the important areas was 0.05% and no microfilaremia were found in these positive cases.22 clinically diagnosed cases and suspected cases were excluded after investigation from 2004 to 2008.3 061 chronic patients and one new chronic patient were found after survey in 26 counties.Conclusion With the implementation of the survey of the infection source,The goal of elimination of filariasis had been achieved and the number of filariasis cases remains consistently low in Hubei.

关 键 词：丝虫病 消除 监测 评价 

分 类 号：R532.15[医药卫生—内科学]